ライフサイエンスコーパス: antitubercular drug

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 the development of a novel chemical class of antitubercular drugs.

2 otential to be developed into a new class of antitubercular drugs.

3 otential target to develop antibacterial and antitubercular drugs.

4 um tuberculosis and is the target of several antitubercular drugs.

5 rculosis (M. tb) emphasizes the need for new antitubercular drugs.

6 M/LM balance might represent targets for new antitubercular drugs.

7 the oxidative activation of other thioamide antitubercular drugs.

8 otential target for the development of novel antitubercular drugs.

9 AGP is also regarded as a target for several antitubercular drugs.

10 afish larvae for in vivo characterization of antitubercular drug activity and tolerance.

11 ation issues, including interactions between antitubercular drugs, antiretroviral drugs, and medicine

12 e originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2), which show

13 MbtA is a validated therapeutic target for antitubercular drug development.

14 dy tuberculosis pathogenesis, as well as for antitubercular drug discovery.

15 g pocket of Eis is a potential target of new antitubercular drugs expected to overcome aminoglycoside

16 The mechanisms of action of the unique antitubercular drugs, including isoniazid, ethambutol, a

17 Isoniazid (INH), a frontline antitubercular drug, inhibits InhA, the enoyl reductase

18 One challenge to the development of new antitubercular drugs is the existence of multiple virule

19 erium marinum to thiacetazone, a second line antitubercular drug, is associated with a severe decreas

20 tuberculosis, is the target of the frontline antitubercular drug isoniazid (INH).

21 The preferred antitubercular drug isoniazid specifically targets a lon

22 obacterium tuberculosis and a target for the antitubercular drug isoniazid.

23 ponsible for activation of the commonly used antitubercular drug, isoniazid (INH).

24 e for increased resistance to the front-line antitubercular drug, isoniazid, by acetylating and hence

25 losis, is important in the activation of the antitubercular drug, isoniazid.

26 sis is responsible for the activation of the antitubercular drug isonicotinic acid hydrazide (INH) an

27 In contrast to current antitubercular drugs, nitroimidazopyrans exhibited bacte

28 ween these two components was provided using antitubercular drugs such as ethambutol or isoniazid kno

29 s is inhibited by isoniazid, a key frontline antitubercular drug that is inactivated by mycobacterial

30 osis highlights the need for identifying new antitubercular drugs that can treat these infections.

31 s the efficacy of ethionamide, a second-line antitubercular drug used to combat multidrug-resistant M

32 However, new antitubercular drugs with new mechanisms of action have

33 ly) TB; hence the quest for highly effective antitubercular drugs with novel modes of action is imper

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。